Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2011
07/14/2011US20110172150 Tissue regeneration method
07/14/2011US20110172114 Compositions and methods for the treatment of immune related diseases
07/14/2011US20110171303 Dosage form containing (s)-pantoprazole as active ingredient
07/14/2011US20110171300 Delta 9 tetrahydrocannabinol derivatives
07/14/2011US20110171295 Immediate release compositions of acid labile drugs
07/14/2011US20110171294 Enzyme composition and application thereof in the treatment of pancreatic insufficiency
07/14/2011US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo
07/14/2011US20110171275 Gastroretentive drug delivery system, preparation method and use thereof
07/14/2011US20110171273 Stable anti-nausea oral spray formulations and methods
07/14/2011US20110171270 Novel solid state forms of laquinimod and its sodium salt
07/14/2011US20110171269 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs
07/14/2011US20110171237 Phep, an amino acid permease of staphylococcus aureus
07/14/2011US20110171220 Pd-1 specific antibodies and uses thereof
07/14/2011US20110171215 Pd-1 specific antibodies and uses thereof
07/14/2011US20110171191 Suppression of neuroendocrine diseases
07/14/2011US20110171178 Compositions and methods of using proislet peptides and analogs thereof
07/14/2011US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds
07/14/2011US20110171144 Functional Micelles for Hard Tissue Targeted Delivery of Chemicals
07/14/2011US20110171143 Method of maintaining oral health in animals
07/14/2011US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin
07/14/2011CA2786056A1 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
07/14/2011CA2786019A1 Plasma kallikrein binding proteins
07/14/2011CA2784647A1 Inhibitors of sphingosine kinase
07/14/2011CA2781260A1 Oral care compositions for use with an oral light device
07/14/2011CA2780821A1 Mmp-13 inhibitors for the treatment of periodontitsis
07/13/2011EP2343316A1 Ligand binding site of RAGE and uses thereof
07/13/2011EP2343314A2 Calcium fluoride phosphopeptide complexes
07/13/2011EP2343292A1 Novel prostaglandin i<sb>2</sb>derivative
07/13/2011EP2343289A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent
07/13/2011EP2343081A1 Interferon analogs
07/13/2011EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
07/13/2011EP2343072A1 Remedy
07/13/2011EP2343067A1 Pharmaceutical composition for the eradication of helicobacter pylori and preparation method thereof
07/13/2011EP2343066A1 Therapeutic agent for hepatitis c
07/13/2011EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
07/13/2011EP2343063A1 Pharmaceutical preparations comprising a COS releasing compound
07/13/2011EP2342335A1 Novel gene cluster
07/13/2011EP2342200A2 Compounds which selectively modulate the cb2 receptor
07/13/2011EP2342199A2 Compounds which selectively modulate the cb2 receptor
07/13/2011EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
07/13/2011EP2341985A1 Dental formulations for the prevention of dental erosion
07/13/2011EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c
07/13/2011EP1863526B1 Live attenuated rotavirus vaccine for oral administration
07/13/2011EP1789068B1 Composition and use for prevention or treatment of stomatitis
07/13/2011EP1543039B1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
07/13/2011EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
07/13/2011EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient
07/13/2011EP1178796B1 Orazamide orotate for the prevention of liver damage
07/13/2011CN1957938B Effervescence tablet of Glucurolactone, and preparation method
07/13/2011CN1353609B Amide substituted imidazoquinolines
07/13/2011CN102123735A Agent for induction/maintenance of remission
07/13/2011CN102123718A Treatment of gut motility disorders
07/13/2011CN102123716A Compositions and methods for treating viral infections
07/13/2011CN102120952A Health wine with functions of nourishing yin and tonifying yang
07/13/2011CN102120773A Dual specificity antibodies and methods of making and using
07/13/2011CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines
07/13/2011CN102120030A Medicament of ilaprazole chemical structure and application thereof
07/13/2011CN102120011A Medicament for treating toothache
07/13/2011CN102120008A Traditional Chinese medicine for treating icteric hepatitis
07/13/2011CN102120007A Medicament for preventing and treating complications caused by <131>I therapy of differentiated thyroid carcinoma (DTC)
07/13/2011CN102120005A Traditional Chinese medicine for soothing liver, regulating qi and promoting bile flow and preparation method and quality standard thereof
07/13/2011CN102119999A Preparation method of oral solution capable of tonifying qi and nourishing blood
07/13/2011CN102119997A Method for establishing HPLC (high performance liquid chromatography) finger-print of ophiopogon japonicus and standard finger-print thereof
07/13/2011CN102119995A Traditional Chinese medicament for treating gum swelling pain
07/13/2011CN102119992A Pharmaceutical preparation prepared from fresh motherwort and fresh aloe and preparation method thereof
07/13/2011CN102119979A 口腔溃疡复方制剂 Mouth ulcers compound preparation
07/13/2011CN102119973A Quality control method for gardenia percolate
07/13/2011CN102119966A Preparation method of Chinese medicinal preparation for treating hepatitis disease by microwave-assisted extraction
07/13/2011CN102119952A Ultrasonic extraction preparation method of Chinese traditional medicine preparation for treating lumbago due to kidney deficiency
07/13/2011CN102119945A Method for preparing ultrasonic extracted Chinese medicinal preparation for treating qi deficiency
07/13/2011CN102119944A Dammarane type glycoside composition particles
07/13/2011CN102119939A Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof
07/13/2011CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine
07/13/2011CN102119933A Application of taurochenodeoxycholic acid in prevention and treatment of liver injury
07/13/2011CN102119927A Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof
07/13/2011CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion
07/13/2011CN102119776A Dried orange peel extract and preparation method and use thereof
07/13/2011CN101690739B Preparation method of dogbane leaf extractive
07/13/2011CN101584702B Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus
07/13/2011CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof
07/13/2011CN101496813B Applicance of combination in drug coating of preparing anti-hyperblastosis (vascular restenosis) support
07/13/2011CN101342229B Composition of Canton love-pea vine extract, preparation method and pharmaceutical use
07/12/2011US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders
07/12/2011US7977455 Analogues of GLP-1
07/12/2011US7977329 Obesity therapy; using 3-benzoazepine compound
07/12/2011US7977326 Supportive treatment of liver disease
07/12/2011US7977316 Prevention and treatment of amyloidogenic diseases
07/12/2011US7977059 17867, a novel human aminopeptidase
07/12/2011US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate
07/12/2011CA2500649C Substituted arylhexadienoic acids and esters thereof, their use in the treatment of dyslipidaemia, diabetes and atherosclerosis, and processes for their preparation
07/12/2011CA2499492C Methods of preparing cannabinoids from plant material
07/12/2011CA2481767C Severe sepsis preventive therapeutic agent
07/12/2011CA2475704C Colonic release formulations of prednisolone sodium metasulphobenzoate coated with amylose, ethyl cellulose and dibutyl sebacate
07/12/2011CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina)
07/12/2011CA2454389C Solid composition containing bacillus-type non-pathogenic bacterial spores
07/12/2011CA2449150C Tricyclic compounds useful as angiotensin ii agonists
07/12/2011CA2446776C Self-containing lactococcus strain
07/12/2011CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives
07/12/2011CA2422617C Tripeptidyl peptidase inhibitors
07/12/2011CA2405438C Hepatitis b core antigen fusion proteins